Tetramer-guided epitope mapping: Rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens

Journal of Immunology

Volumn 166, Issue 11, 2001, Pages 6665-6670

  Novak, Erik J ^a,b   Liu, Andrew W ^a   Gebe, John A ^a   Falk, Ben A ^a   Nepom, Gerald T ^a   Koelle, David M ^b,c   Kwok, William W ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE;

ANTIGEN EXPRESSION; ARTICLE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035338812     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.11.6665     Document Type: Article

References (39)

1. Chang, K. M., N. H. Gruener, S. Southwood, J. Sidney, G. R. Pape, F. V. Chisari, and A. Sette. 1999. Identitication of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J. Immunol. 162:1156.
2. Rolland, J., and R. O'Hehir. 1998. Immunotherapy of allergy: anergy, deletion, and immune deviation. Curr. Opin. Immunol. 10:640.
3. Wicker, L. S., S. L. Chen, G. T. Nepom, J. F. Elliott, D. C. Freed, A. Bansal, S. Zheng, A. Herman, A. Lernmark, D. M. Zaller, et al. 1996. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB 1*0401. J. Clin. Invest. 98:2517.
4. Falk, K., O. Rotzschke, L. Santambrogio, M. E. Dorf, C. Brosnan, and J. L. Strominger. 2000. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides. J. Exp. Med. 191:717.
5. Wang, R. F., and S. A. Rosenberg. 1999. Human tumor antigens for cancer vaccine development. Immunol. Rev. 170:85.
6. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
7. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395.
8. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383.
9. + T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188:785.
10. Lee, P. P., C. Yee, P. A. Savage, L. Fong, D. Brockstedt, J. S. Weber, D. Johnson, S. Swetter, J. Thompson, P. D. Greenberg, M. Roederer, and M. M. Davis. 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:677.
11. + T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 190:705.
12. Dunbar, P. R., J. L. Chen, D. Chao, N. Rust, H. Teisserene, G. S. Ogg, P. Romero, P. Weynants, and V. Cerundolo. 1999. Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. J. Immunol. 162:6959.
13. Molldrem, J. J., P. P. Lee, C. Wang, R. E. Champlin, and M. M. Davis. 1999. A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia. Cancer Res. 59:2675.
14. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8:675.
15. Kotzin, B. L., M. T. Falta, F. Crawford, E. F. Rosloniec, J. Bill, P. Marrack, and J. Kappler. 2000. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 97:291.
16. Gutgemann, I., A. M. Fahrer, J. D. Altman, M. M. Davis, and Y. H. Chien. 1998. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8:667.
17. Savage, P. A., J. J. Boniface, and M. M. Davis. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10:485.
18. + T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104:R63.
19. Kwok, W. W., A. W. Liu, E. J. Novak, J. A. Gebe, R. A. Ettinger, G. T. Nepom, S. N. Reymond, and D. M. Koelle. 2000. HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells. J. Immunol. 164:4244.
20. + T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J. Virol. 68:2803.
21. Koelle, D. M., J. M. Frank, M. L. Johnson, and W. W. Kwok. 1998. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J. Virol. 72:7476.
22. Horton, R. M., Z. L. Cai, S. N. Ho, and L. R. Pease. 1990. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Bio-Techniques 8:528.
23. Chang, H. C., Z. Bao, Y. Yao, A. G. Tse, E. C. Goyarts, M. Madsen, E. Kawasaki, P. P. Brauer, J. C. Sacchettini, and S. G. Nathenson. 1994. A general method for facilitating heterodimeric pairing between two proteins: application to expression of α and β T-cell receptor extracellular segments. Proc. Natl. Acad. Sci. USA 91:11408.
24. Schatz, P. J. 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology 11:1138.
25. Kern, F., I. P. Surel, C. Brock, B. Freistedt, H. Radtke, A. Scheffold, R. Blasczyk, P. Reinke, J. Schneider-Mergener, A. Radbruch, P. Walden, and H. D. Volk. 1998. T-cell epitope mapping by flow cytometry. Nat. Med. 4:975.
26. +-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 73:8179.
27. Kovats, S., G. T. Nepom, M. Coleman, B. Nepom, W. W. Kwok, and J. S. Blum. 1995. Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J. Clin. Invest. 96:217.
28. Ettinger, R. A., and W. W. Kwok. 1998. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. J. Immunol. 160:2365.
29. + T cells based on cytokine secretion. Eur. J. Immunol. 29:4053.
30. Sette, A., J. Sidney, C. Oseroff, M.-F. del Guercio, S. Southwood, T. Arrhenius, M. F. Powell, S. M. Colon, F. C. A. Gaeta, and H. M. Grey. 1993. HLA-DR4Dw4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151:3163.
31. Marshall, K. W., K. J. Wilson, J. Liang, A. Woods, D. Zaller, and J. B. Rothbard. 1995. Prediction of peptide affinity to HLA DRB1*0401. J. Immunol. 154:5927.
32. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
33. Demotz, S., C. Barbey, G. Corradin, A. Amoroso, and A. Lanzavecchia. 1993. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur. J. Immunol. 23:425.
34. Dessen, A., C. M. Lawrence, S. Cupo, D. M. Zaller, and D. C. Wiley. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen H. Immunity 7:473.
35. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827.
36. Rabinowitz, J. D., M. Vrljic, P. M. Kasson, M. N. Liang, R. Busch, J. J. Boniface, M. M. Davis, and H. M. McConnell. 1998. Formation of a highly peptide-receptive state of class II MHC. Immunity 9:699.
37. Cochran, J. R., T. O. Cameron, and L. J. Stern. 2000. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 12:241.
38. Kern, F., N. Faulhaber, C. Frommel, E. Khatamzas, S. Prosch, C. Schonemann, I. Kretzschmar, R. Volkmer-Engert, H. D. Volk, and P. Reinke. 2000. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol. 30:1676.
39. Udaka, K., K. H. Wiesmüller, S. Kienle, S. Feiertag, G. Jung, and P. Walden. 1996. Random peptide libraries as tools in basic and applied immunology. In Combinatorial Peptide and Nonpeptide Libraries. G. Jung, ed. VCH Verlagsgesellschaft mbH. Weinheim, p. 349-362.